BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci

Philip Domenico1, Ellen Gurzenda, Andrea Giacometti

  • 1Cardio Pulmonary Research Institute, Winthrop-University Hospital, SUNY Stony Brook School of Medicine, Mineola 11501, New York, NY, USA. pdomenico@winthrop.org

Peptides
|December 2, 2004
PubMed

Insights

Combining RNAIII-inhibiting peptide (RIP) and Bismuth ethanedithiol (BisEDT) effectively prevented staphylococcal infections and biofilm formation on medical devices in a rat model, reducing bacterial load to undetectable levels.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biomaterials Science

Background:

  • Staphylococcal infections are common with indwelling medical devices.
  • Biofilm formation by Staphylococci contributes to antibiotic resistance.
  • Quorum sensing mechanisms are key to staphylococcal pathogenesis and biofilm development.

Purpose of the Study:

  • To evaluate the efficacy of RNAIII-inhibiting peptide (RIP) and Bismuth ethanedithiol (BisEDT), alone and in combination, in preventing staphylococcal infections and biofilm formation.
  • To assess the effectiveness against both antibiotic-sensitive and resistant strains of Staphylococcus aureus and Staphylococcus epidermidis.

Main Methods:

  • A rat graft model was used to simulate medical device-associated infections.
  • Treatment groups included BisEDT, RIP, rifampin, and their combinations.
  • Bacterial load on grafts was quantified over a seven-day period.

Main Results:

  • All tested agents (BisEDT, RIP, rifampin) and their combinations reduced graft-associated bacterial load.
  • The combination of BisEDT and RIP demonstrated the most significant reduction in bacterial levels.
  • The BisEDT-RIP combination reduced bacterial load to undetectable levels.

Conclusions:

  • The combination of BisEDT and RIP is highly effective in preventing staphylococcal infections and biofilm formation.
  • BisEDT-RIP holds promise for coating medical devices to mitigate device-associated staphylococcal infections.
  • This combination therapy offers a potential strategy against antibiotic-resistant staphylococcal strains.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...